Call for Abstract

2nd International Conference and Exhibition on Neurology & Therapeutics, will be organized around the theme “Emerging Trends in Neurological Therapeutics”

Neuro-2013 is comprised of 12 tracks and 65 sessions designed to offer comprehensive sessions that address current issues in Neuro-2013.

Submit your abstract to any of the mentioned tracks. All related abstracts are accepted.

Register now for the conference by choosing an appropriate package suitable to you.

  • Track 1-1Systems, cognitive and behavioral neuroscience
  • Track 1-2Neural circuits and neural systems
  • Track 1-3 Advances and anatomical methods of physiology
  • Track 1-4Glial cells and homeostasis
  • Track 2-1 Function of preganglionic and ganglionic neurons
  • Track 2-2Afferent and efferent neurons
  • Track 2-3Neurotransmission
  • Track 2-4Neuroplasticity
  • Track 3-1Genetics and epidemiology of huntington disease
  • Track 3-2Parkinson's disease, and alzheimer's disease
  • Track 3-3Aging, ataxias, prion diseases, down syndrome
  • Track 3-4Psychological disorders
  • Track 3-5Training an alzheimer's friendly healthcare workforce
  • Track 4-1Clinical neurophysiology and addiction medicine
  • Track 4-2 Psychiatry and psychosurgery
  • Track 4-3Neuropathology and neuroradiology
  • Track 4-4Trauma and treatment
  • Track 5-1Connectionism and neural networks for drug discovery
  • Track 5-2Neuroinformatics
  • Track 5-3Neuro engineering and machine learning
  • Track 5-4Electrophysiology
  • Track 6-1Electromyography and electrocorticography
  • Track 6-2Polysomnography
  • Track 6-3 Electroencephalography
  • Track 6-4MR spectroscopy, MR tractography & cerebral tumor imaging
  • Track 6-5Functional magnetic resonance imaging
  • Track 6-6Steady state topography
  • Track 7-1Non-glial tumors and imaging
  • Track 7-2Epidemiology and neurotoxicity
  • Track 7-3Advances in neurosurgery for brain tumors
  • Track 7-4Non-glial tumors and imaging
  • Track 7-5Epidemiology and neurotoxicity
  • Track 7-6Neurocognitive toxicities of treatment of brain metastasis
  • Track 7-7Therapeutic approaches in treatment of gliomas
  • Track 7-8Advances in neurosurgery for brain tumors
  • Track 7-9Neurocognitive toxicities of treatment of brain metastasis
  • Track 7-10Therapeutic approaches in treatment of gliomas
  • Track 8-1Sleep disorders, and Epilepsy
  • Track 8-2AMPA, NMDA, GABA, glutamine, cytokines, neurotrophins, and acetylcholine
  • Track 8-3Acetylcholine, norepinephrine, monoamines, and dopamine for neuropharmacology
  • Track 8-4Therapeutics potential of neurosteroids
  • Track 8-5Neurophysiology: Ion channels
  • Track 8-6Neuromuscular disorders and demyelinating diseases
  • Track 9-1Immnuotherapy and biomarker
  • Track 9-2Biomarker for chronic neurological diseases
  • Track 9-3Genomic and proteomic biomarker
  • Track 9-4Targeted nanoparticles applications
  • Track 9-5Neurophysiological and clinical applications
  • Track 9-6Nanoscience and neurosurgery
  • Track 9-7Novel methods of drug delivery
  • Track 9-8Innovative methods of regenerating CNS tissues
  • Track 9-9Pregnency and drug research
  • Track 10-1Case studies of neurodegenerative disorders
  • Track 10-2Case studies of movement disorders
  • Track 10-3Case studies of psychiatry
  • Track 10-4Case studies of neurosurgery
  • Track 11-1Neurofeedback
  • Track 11-2Electromyography biofeedback
  • Track 11-3Temperature biofeedback
  • Track 11-4Galvanic skin response training
  • Track 11-5Heart rate variability biofeedback
  • Track 12-1Future of neuromarketing, ideas and critics
  • Track 12-2First-rate practices
  • Track 12-3The mind of the consumer
  • Track 12-4Modus operandi-tools and techniques